Hypoglycaemia downregulates endotoxin-induced production of tumour necrosis factor-α, but does not affect IL-1β, IL-6, or IL-10

This publication has 25 references indexed in Scilit:

• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• Antiinflammatory Cytokine Responses during Clinical Sepsis and Experimental Endotoxemia: Sequential Measurements of Plasma Soluble Interleukin (IL)-1 Receptor Type II, IL-10, and IL-13
  The Journal of Infectious Diseases, 1997
• Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro
  Diabetes, 1996
• Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia.
  Journal of Clinical Investigation, 1996
• Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM
  Diabetes, 1994
• Effects of trauma, duration of hypotension, and resuscitation regimen on cellular immunity after hemorrhagic shock
  Critical Care Medicine, 1994
• In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus
  Journal of Clinical Endocrinology & Metabolism, 1993
• Serum levels of IL-1, IL-6 and tumour necrosis factors in patients undergoing coronary artery bypass grafts or cholecystectomy
  Clinical and Experimental Immunology, 1992
• Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
  The Journal of Experimental Medicine, 1991
• Surgery, Trauma and Immune Suppression Evolving the Mechanism
  Annals of Surgery, 1983